Calcitonin and calcitonin receptor-like receptors: Common themes with family B GPCRs?

British Journal of Pharmacology

Volumn 166, Issue 1, 2012, Pages 51-65

  Barwell, James ^a   Gingell, Joseph J ^b   Watkins, Harriet A ^b   Archbold, Julia K ^b,c   Poyner, David R ^a   Hay, Debbie L ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c MONASH UNIVERSITY   (Australia)

Author keywords

adrenomedullin; amylin; calcitonin; CGRP; domain; GPCR; helix cap; juxtamembrane domain; RAMP; receptor activation; receptor activity modifying protein

Indexed keywords

CALCITONIN; CALCITONIN RECEPTOR LIKE RECEPTOR; G PROTEIN COUPLED RECEPTOR; RECEPTOR ACTIVITY MODIFYING PROTEIN;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; HUMAN; LIGAND BINDING; NONHUMAN; OLIGOMERIZATION; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; CALCITONIN; CALCITONIN RECEPTOR-LIKE PROTEIN; HUMANS; LIGANDS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEINS; RECEPTORS, CALCITONIN;

EID: 84859310855     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01525.x     Document Type: Review

References (109)

1. Al-Sabah S, Donnelly D, (2003). The positive charge at Lys-288 of the glucagon-like peptide-1 (GLP-1) receptor is important for binding the N-terminus of peptide agonists. FEBS Lett 553: 342-346.
2. Andreotti, G, Vitale, RR, Avidan-Shpalter, C, Amodeo, P, Gazit, E, Motta, A, (2011). Converting the highly amyloidogenic human calcitonin into a powerful fibril inhibitor by three-dimensional structure homology with a non-amyloidogenic analogue. J Biol Chem 286: 2707-2718.
3. Assil-Kishawi I, Abou-Samra AB, (2002). Sauvagine cross-links to the second extracellular loop of the corticotropin-releasing factor type 1 receptor. J Biol Chem 277: 32558-32561.
4. Assil-Kishawi I, Samra TA, Mierke DF, Abou-Samra AB, (2008). Residue 17 of Sauvagine Cross-links to the first transmembrane domain of corticotropin-releasing factor receptor 1 (CRFR1). J Biol Chem 283: 35644-35651.
5. Bailey RJ, Hay DL, (2007). Agonist-dependent consequences of proline to alanine substitution in the transmembrane helices of the calcitonin receptor. Br J Pharmacol 151: 678-687.
6. Banerjee S, Evanson J, Harris E, Lowe SL, Thomasson KA, Porter JE, (2006). Identification of specific calcitonin-like receptor residues important for calcitonin gene-related peptide high affinity binding. BMC Pharmacol 6: 9.
7. Barwell J, Miller PS, Donnelly D, Poyner DR, (2010). Mapping interaction sites within the N-terminus of the calcitonin gene-related peptide receptor; the role of residues 23-60 of the calcitonin receptor-like receptor. Peptides 31: 170-176.
8. Bergwitz C, Gardella TJ, Flannery MR, Potts JT Jr, Kronenberg HM, Goldring SR, et al,. (1996). Full activation of chimeric receptors by hybrids between parathyroid hormone and calcitonin. Evidence for a common pattern of ligand-receptor interaction. J Biol Chem 271: 26469-26472.
9. Bergwitz C, Jusseaume SA, Luck MD, Juppner H, Gardella TJ, (1997). Residues in the membrane-spanning and extracellular loop regions of the parathyroid hormone (PTH)-2 receptor determine signaling selectivity for PTH and PTH-related peptide. J Biol Chem 272: 28861-28868.
10. Bissantz C, Logean A, Rognan D, (2004). High-throughput modeling of human G-protein coupled receptors: amino acid sequence alignment, three-dimensional model building, and receptor library screening. J Chem Inf Comput Sci 44: 1162-1176.
11. Chan KY, Pang RT, Chow BK, (2001). Functional segregation of the highly conserved basic motifs within the third endoloop of the human secretin receptor. Endocrinology 142: 3926-3934.
12. Christopoulos A, Christopoulos G, Morfis M, Udawela M, Laburthe M, Couvineau A, et al,. (2003). Novel receptor partners and function of receptor activity-modifying proteins. J Biol Chem 278: 3293-3297.
13. Chugunov AO, Simms J, Poyner DR, Dehouck Y, Rooman M, Gilis D, et al,. (2010). Evidence that interaction between conserved residues in transmembrane helices 2, 3, and 7 are crucial for human VPAC1 receptor activation. Mol Pharmacol 78: 394-401.
14. Conner AC, Hay DL, Simms J, Howitt SG, Schindler M, Smith DM, et al,. (2005). A key role for transmembrane prolines in calcitonin receptor-like receptor agonist binding and signalling: implications for family B G-protein-coupled receptors. Mol Pharmacol 67: 20-31.
15. Conner AC, Simms J, Conner MT, Wootten DL, Wheatley M, Poyner DR, (2006a). Diverse functional motifs within the three intracellular loops of the CGRP1 receptor. Biochemistry 45: 12976-12985.
16. Conner AC, Simms J, Howitt SG, Wheatley M, Poyner DR, (2006b). The Second Intracellular Loop of the Calcitonin Gene-related Peptide Receptor Provides Molecular Determinants for Signal Transduction and Cell Surface Expression. J Biol Chem 281: 1644-1651.
17. Conner AC, Simms J, Barwell J, Wheatley M, Poyner DR, (2007). Ligand binding and activation of the CGRP receptor. Biochem Soc Trans 35: 729-732.
18. Conner M, Hicks MR, Dafforn T, Knowles TJ, Ludwig C, Staddon S, et al,. (2008). Functional and biophysical analysis of the C-terminus of the CGRP-receptor; a family B GPCR. Biochemistry 47: 8434-8444.
19. Couvineau A, Lacapere JJ, Tan YV, Rouyer-Fessard C, Nicole P, Laburthe M, (2003). Identification of cytoplasmic domains of hVPAC1 receptor required for activation of adenylyl cyclase. Crucial role of two charged amino acids strictly conserved in class II G protein-coupled receptors. J Biol Chem 278: 24759-24766.
20. Di Fabio R, Arban R, Bernasconi G, Braggio S, Blaney FE, Capelli AM, et al,. (2008). Dihydropyrrole[2,3-d]pyridine derivatives as novel corticotropin-releasing factor-1 antagonists: mapping of the receptor binding pocket by in silico docking studies. J Med Chem 51: 7273-7286.
21. Di Paolo E, De Neef P, Moguilevsky N, Petry H, Bollen A, Waelbroeck M, et al,. (1998). Contribution of the second transmembrane helix of the secretin receptor to the positioning of secretin. FEBS Lett 424: 207-210.
22. Di Paolo E, Vilardaga JP, Petry H, Moguilevsky N, Bollen A, Robberecht P, et al,. (1999). Role of charged amino acids conserved in the vasoactive intestinal polypeptide/secretin family of receptors on the secretin receptor functionality. Peptides 20: 1187-1193.
23. Dong M, Pinon DI, Cox RF, Miller LJ, (2004a). Importance of the amino terminus in secretin family G protein-coupled receptors. Intrinsic photoaffinity labeling establishes initial docking constraints for the calcitonin receptor. J Biol Chem 279: 1167-1175.
24. Dong M, Pinon DI, Cox RF, Miller LJ, (2004b). Molecular approximation between a residue in the amino-terminal region of calcitonin and the third extracellular loop of the class B G protein-coupled calcitonin receptor. J Biol Chem 279: 31177-31182.
25. Dong M, Cox RF, Miller LJ, (2009). Juxtamembranous region of the amino terminus of the family B G protein-coupled calcitonin receptor plays a critical role in small-molecule agonist action. J Biol Chem 284: 21839-21847.
26. Dong M, Lam PC, Pinon DI, Orry A, Sexton PM, Abagyan R, et al,. (2010a). Secretin occupies a single protomer of the homodimeric secretin receptor complex: insights from photoaffinity labeling studies using dual sites of covalent attachment. J Biol Chem 285: 9919-9931.
27. Dong M, Pinon DI, Bordner AJ, Miller LJ, (2010b). Elucidation of the active conformation of the amino terminus of receptor-bound secretin using intramolecular disulfide bond constraints. Bioorg Med Chem Lett 20: 6040-6044.
28. Donnelly D, (1997). The arrangement of the transmembrane helices in the secretin receptor family of G-protein-coupled receptors. FEBS Lett 409: 431-436.
29. Evans BN, Rosenblatt MI, Mnayer LO, Oliver KR, Dickerson IM, (2000). CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem 275: 31438-31443.
30. Findlay DM, Houssami S, Lin HY, Myers DE, Brady CL, Darcy PK, et al,. (1994). Truncation of the porcine calcitonin receptor cytoplasmic tail inhibits internalization and signal transduction but increases receptor affinity. Mol Endocrinol 8: 1691-1700.
31. Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB, (2003). The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63: 1256-1272.
32. Frimurer TM, Bywater RP, (1999). Structure of the integral membrane domain of the GLP1 receptor. Proteins 35: 375-386.
33. Gao F, Harikumar KG, Dong M, Lam PC, Sexton PM, Christopoulos A, et al,. (2009). Functional importance of a structurally distinct homodimeric complex of the family B G protein-coupled secretin receptor. Mol Pharmacol 76: 264-274.
34. Gensure RC, Shimizu N, Tsang J, Gardella TJ, (2003). Identification of a contact site for residue 19 of parathyroid hormone (PTH) and PTH-related protein analogs in transmembrane domain two of the type 1 PTH receptor. Mol Endocrinol 17: 2647-2658.
35. Gesty-Palmer D, Flannery P, Yuan L, Corsino L, Spurney R, Lefkowitz RJ, et al,. (2009). A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. Sci Transl Med 1: 1ra1.
36. Gkountelias K, Tselios T, Venihaki M, Deraos G, Lazaridis I, Rassouli O, et al,. (2009). Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding. Mol Pharmacol 75: 793-800.
37. Granseth E, von Heijne G, Elofsson A, (2005). A study of the membrane-water interface region of membrane proteins. J Mol Biol 346: 377-385.
38. Greenberg Z, Bisello A, Mierke DF, Rosenblatt M, Chorev M, (2000). Mapping the bimolecular interface of the parathyroid hormone (PTH)-PTH1 receptor complex: spatial proximity between Lys(27) (of the hormone principal binding domain) and leu(261) (of the first extracellular loop) of the human PTH1 receptor. Biochemistry 39: 8142-8152.
39. Gujer R, Aldecoa A, Buhlmann N, Leuthauser K, Muff R, Fischer JA, et al,. (2001). Mutations of the asparagine117 residue of a receptor activity-modifying protein 1-dependent human calcitonin gene-related peptide receptor result in selective loss of function. Biochemistry 40: 5392-5398.
40. ter Haar E, Koth CM, Abdul-Manan N, Swenson L, Coll JT, Lippke JA, et al,. (2010). Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure 18: 1083-1093.
41. Harikumar KG, Lam PC, Dong M, Sexton PM, Abagyan R, Miller LJ, (2007). Fluorescence resonance energy transfer analysis of secretin docking to its receptor: mapping distances between residues distributed throughout the ligand pharmacophore and distinct receptor residues. J Biol Chem 282: 32834-32843.
42. Harikumar KG, Morfis MM, Sexton PM, Miller LJ, (2008). Pattern of intra-family hetero-oligomerization involving the G-protein-coupled secretin receptor. J Mol Neurosci 36: 279-285.
43. Harikumar KG, Simms J, Christopoulos G, Sexton PM, Miller LJ, (2009). Molecular basis of association of receptor activity-modifying protein 3 with the family B G protein-coupled secretin receptor. Biochemistry 48: 11773-11785.
44. Harikumar KG, Ball AM, Sexton PM, Miller LJ, (2010). Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerization. Regul Pept 164: 113-119.
45. Hay DL, Poyner DR, Sexton PM, (2006). GPCR modulation by RAMPs. Pharmacol Ther 109: 173-197.
46. Heroux M, Hogue M, Lemieux S, Bouvier M, (2007). Functional calcitonin gene-related peptide receptors are formed by the asymmetric assembly of a calcitonin receptor-like receptor homo-oligomer and a monomer of receptor activity-modifying protein-1. J Biol Chem 282: 31610-31620.
47. Hilairet S, Foord SM, Marshall FH, Bouvier M, (2001). Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins. J Biol Chem 276: 29575-29581.
48. Hoare SR, (2005). Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors. Drug Discov Today 10: 417-427.
49. Holtmann MH, Hadac EM, Miller LJ, (1995). Critical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. Studies of chimeric receptors. J Biol Chem 270: 14394-14398.
50. Holtmann MH, Ganguli S, Hadac EM, Dolu V, Miller LJ, (1996). Multiple extracellular loop domains contribute critical determinants for agonist binding and activation of the secretin receptor. J Biol Chem 271: 14944-14949.
51. Houssami S, Findlay DM, Brady CL, Martin TJ, Epand RM, Moore EE, et al,. (1995). Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation. Mol Pharmacol 47: 798-809.
52. Inooka H, Ohtaki T, Kitahara O, Ikegami T, Endo S, Kitada C, et al,. (2001). Conformation of a peptide ligand bound to its G-protein coupled receptor. Nat Struct Biol 8: 161-165.
53. Ittner LM, Luessi F, Koller D, Born W, Fischer JA, Muff R, (2004). Aspartate (69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2. Biochem Biophys Res Commun 319: 1203-1209.
54. Ittner LM, Koller D, Muff R, Fischer JA, Born W, (2005). The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1. Biochemistry 44: 5749-5754.
55. Johnson MS, Overington JP, (1993). A structural basis for sequence comparisons. An evaluation of scoring methodologies. J Mol Biol 233: 716-738.
56. Johnston CA, Kimple AJ, Giguere PM, Siderovski DP, (2008). Structure of the parathyroid hormone receptor C terminus bound to the G-protein dimer Gbeta1gamma2. Structure 16: 1086-1094.
57. Knudsen SM, Tams JW, Fahrenkrug J, (2001). Functional roles of conserved transmembrane prolines in the human VPAC (1) receptor. FEBS Lett 503: 126-130.
58. Kolakowski LF Jr, (1994). GCRDb: a G-protein-coupled receptor database. Receptors Channels 2: 1-7.
59. Koller D, Born W, Leuthauser K, Fluhmann B, McKinney RA, Fischer JA, et al,. (2002). The extreme N-terminus of the calcitonin-like receptor contributes to the selective interaction with adrenomedullin or calcitonin gene-related peptide. FEBS Lett 531: 464-468.
60. Kraetke O, Holeran B, Berger H, Escher E, Bienert M, Beyermann M, (2005). Photoaffinity cross-linking of the corticotropin-releasing factor receptor type 1 with photoreactive urocortin analogues. Biochemistry 44: 15569-15577.
61. Kumar S, Pioszak A, Zhang C, Swaminathan K, Xu HE, (2011). Crystal structure of the PAC1R extracellular domain unifies a consensus fold for hormone recognition by Class B G-protein coupled receptors. PLoS One 6: e19682.
62. Kuwasako K, Kitamura K, Nagata S, Hikosaka T, Kato J, (2010). Function of the cytoplasmic tail of human calcitonin receptor-like receptor in complex with receptor activity-modifying protein 2. Biochem Biophys Res Commun 392: 380-385.
63. Kuwasako K, Kitamura K, Nagata S, Hikosaka T, Kato J, (2011). Structure-function analysis of helix 8 of human calcitonin receptor-like receptor within the adrenomedullin 1 receptor. Peptides 32: 144-149.
64. Langer I, Robberecht P, (2007). Molecular mechanisms involved in vasoactive intestinal peptide receptor activation and regulation: current knowledge, similarities to and differences from the A family of G-protein-coupled receptors. Biochem Soc Trans 35: 724-728.
65. Langer I, Langlet C, Robberecht P, (2005). Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor. J Mol Endocrinol 34: 405-414.
66. Langlet C, Langer I, Vertongen P, Gaspard N, Vanderwinden JM, Robberecht P, (2005). Contribution of the carboxyl terminus of the VPAC1 receptor to agonist-induced receptor phosphorylation, internalization, and recycling. J Biol Chem 280: 28034-28043.
67. Liang J, Adamian L, Jackups R Jr, (2005). The membrane-water interface region of membrane proteins: structural bias and the anti-snorkeling effect. Trends Biochem Sci 30: 355-357.
68. Liaw CW, Grigoriadis DE, Lorang MT, De Souza EB, Maki RA, (1997). Localization of agonist- and antagonist-binding domains of human corticotropin-releasing factor receptors. Mol Endocrinol 11: 2048-2053.
69. Lopez de Maturana R, Donnelly D, (2002). The glucagon-like peptide-1 receptor binding site for the N-terminus of GLP-1 requires polarity at Asp198 rather than negative charge. FEBS Lett 530: 244-248.
70. Lopez de Maturana R, Treece-Birch J, Abidi F, Findlay JB, Donnelly D, (2004). Met-204 and Tyr-205 are together important for binding GLP-1 receptor agonists but not their N-terminally truncated analogues. Protein Pept Lett 11: 15-22.
71. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, et al,. (1998). RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393: 333-339.
72. Mathi SK, Chan Y, Li X, Wheeler MB, (1997). Scanning of the glucagon-like peptide-1 receptor localizes G protein-activating determinants primarily to the N terminus of the third intracellular loop. Mol Endocrinol 11: 424-432.
73. Mierke DF, Mao L, Pellegrini M, Piserchio A, Plati J, Tsomaia N, (2007). Structural characterization of the parathyroid hormone receptor domains determinant for ligand binding. Biochem Soc Trans 35: 721-723.
74. Miller LJ, Chen Q, Lam PC, Pinon DI, Sexton PM, Abagyan R, et al,. (2011). Refinement of glucagon-like peptide 1 docking to its intact receptor using mid-region photolabile probes and molecular modeling. J Biol Chem (in press).
75. Monaghan P, Thomas BE, Woznica I, Wittelsberger A, Mierke DF, Rosenblatt M, (2008). Mapping peptide hormone-receptor interactions using a disulfide-trapping approach. Biochemistry 47: 5889-5895.
76. Moore EE, Kuestner RE, Stroop SD, Grant FJ, Matthewes SL, Brady CL, et al,. (1995). Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript. Mol Endocrinol 9: 959-968.
77. Moore EL, Gingell JJ, Kane SA, Hay DL, Salvatore CA, (2010). Mapping the CGRP receptor ligand binding domain: Tryptophan-84 of RAMP1 is critical for agonist and antagonist binding. Biochem Biophys Res Commun 394: 141-145.
78. Morfis M, Tilakaratne N, Furness SG, Christopoulos G, Werry TD, Christopoulos A, et al,. (2008). Receptor activity-modifying proteins differentially modulate the G protein-coupling efficiency of amylin receptors. Endocrinology 149: 5423-5431.
79. Nag K, Kato A, Nakada T, Hoshijima K, Mistry AC, Takei Y, et al,. (2006). Molecular and functional characterization of adrenomedullin receptors in pufferfish. Am J Physiol Regul Integr Comp Physiol 290: R467-R478.
80. Neumann JM, Couvineau A, Murail S, Lacapere JJ, Jamin N, Laburthe M, (2008). Class-B GPCR activation: is ligand helix-capping the key? Trends Biochem Sci 33: 314-319.
81. Parthier C, Reedtz-Runge S, Rudolph R, Stubbs MT, (2009). Passing the baton in class B GPCRs: peptide hormone activation via helix induction? Trends Biochem Sci 34: 303-310.
82. Peeters MC, van Westen GJ, Li Q, Ijzerman AP, (2011). Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation. Trends Pharmacol Sci 32: 35-42.
83. Pham V, Dong M, Wade JD, Miller LJ, Morton CJ, Ng HL, et al,. (2005). Insights into interactions between the alpha-helical region of the salmon calcitonin antagonists and the human calcitonin receptor using photoaffinity labeling. J Biol Chem 280: 28610-28622.
84. Pioszak AA, Harikumar KG, Parker NR, Miller LJ, Xu HE, (2010). Dimeric arrangement of the parathyroid hormone receptor and a structural mechanism for ligand-induced dissociation. J Biol Chem 285: 12435-12444.
85. Piserchio A, Bisello A, Rosenblatt M, Chorev M, Mierke DF, (2000). Characterization of parathyroid hormone/receptor interactions: structure of the first extracellular loop. Biochemistry 39: 8153-8160.
86. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, et al,. (2002). International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54: 233-246.
87. Roh J, Chang CL, Bhalla A, Klein C, Hsu SY, (2004). Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem 279: 7264-7274.
88. Rosenkilde MM, Benned-Jensen T, Frimurer TM, Schwartz TW, (2010). The minor binding pocket: a major player in 7TM receptor activation. Trends Pharmacol Sci 31: 567-574.
89. Rost B, (1999). Twilight zone of protein sequence alignments. Protein Eng 12: 85-94.
90. Rovati GE, Capra V, Neubig RR, (2007). The Highly Conserved DRY Motif of Class A G Protein-Coupled Receptors: beyond the Ground State. Mol Pharmacol 71: 959-964.
91. Runge S, Gram C, Brauner-Osborne H, Madsen K, Knudsen LB, Wulff BS, (2003). Three distinct epitopes on the extracellular face of the glucagon receptor determine specificity for the glucagon amino terminus. J Biol Chem 278: 28005-28010.
92. Salvatore CA, Mallee JJ, Bell IM, Zartman CB, Williams TM, Koblan KS, et al,. (2006). Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor. Biochemistry 45: 1881-1887.
93. Seck T, Baron R, Horne WC, (2003). The alternatively spliced deltae13 transcript of the rabbit calcitonin receptor dimerizes with the C1a isoform and inhibits its surface expression. J Biol Chem 278: 23085-23093.
94. Seck T, Pellegrini M, Florea AM, Grignoux V, Baron R, Mierke DF, et al,. (2005). The delta e13 isoform of the calcitonin receptor forms a six-transmembrane domain receptor with dominant-negative effects on receptor surface expression and signaling. Mol Endocrinol 19: 2132-2144.
95. Sexton PM, Poyner DR, Simms J, Christopoulos A, Hay DL, (2009). Modulating receptor function through RAMPs: can they represent drug targets in themselves? Drug Discov Today 14: 413-419.
96. Sheikh SP, Vilardarga JP, Baranski TJ, Lichtarge O, Iiri T, Meng EC, et al,. (1999). Similar structures and shared switch mechanisms of the beta2-adrenoceptor and the parathyroid hormone receptor. Zn(II) bridges between helices III and VI block activation. J Biol Chem 274: 17033-17041.
97. Solano RM, Langer I, Perret J, Vertongen P, Juarranz MG, Robberecht P, et al,. (2001). Two basic residues of the h-VPAC1 receptor second transmembrane helix are essential for ligand binding and signal transduction. J Biol Chem 276: 1084-1088.
98. Stroop SD, Nakamuta H, Kuestner RE, Moore EE, Epand RM, (1996). Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane-loop regions. Endocrinology 137: 4752-4756.
99. Sydow S, Flaccus A, Fischer A, Spiess J, (1999). The role of the fourth extracellular domain of the rat corticotropin-releasing factor receptor type 1 in ligand binding. Eur J Biochem 259: 55-62.
100. Takhar S, Gyomorey S, Su RC, Mathi SK, Li X, Wheeler MB, (1996). The third cytoplasmic domain of the GLP-1[7-36 amide] receptor is required for coupling to the adenylyl cyclase system. Endocrinology 137: 2175-2178.
101. Thomas BE, Woznica I, Mierke DF, Wittelsberger A, Rosenblatt M, (2008). Conformational changes in the parathyroid hormone receptor associated with activation by agonist. Mol Endocrinol 22: 1154-1162.
102. Thomas BE, Sharma S, Mierke DF, Rosenblatt M, (2009). PTH and PTH antagonist induce different conformational changes in the PTHR1 receptor. J Bone Miner Res 24: 925-934.
103. Turner PR, Bambino T, Nissenson RA, (1996). Mutations of neighboring polar residues on the second transmembrane helix disrupt signaling by the parathyroid hormone receptor. Mol Endocrinol 10: 132-139.
104. Udawela M, Christopoulos G, Tilakaratne N, Christopoulos A, Albiston A, Sexton PM, (2006). Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors. Mol Pharmacol 69: 1984-1989.
105. Vilardaga JP, Di Paolo E, Bialek C, De Neef P, Waelbroeck M, Bollen A, et al,. (1997). Mutational analysis of extracellular cysteine residues of rat secretin receptor shows that disulfide bridges are essential for receptor function. Eur J Biochem 246: 173-180.
106. Vilardaga JP, Frank M, Krasel C, Dees C, Nissenson RA, Lohse MJ, (2001). Differential conformational requirements for activation of G proteins and the regulatory proteins arrestin and G protein-coupled receptor kinase in the G protein-coupled receptor for parathyroid hormone (PTH)/PTH-related protein. J Biol Chem 276: 33435-33443.
107. Vohra S, Chintapalli SV, Illingworth CJ, Reeves PJ, Mullineaux PM, Clark HS, et al,. (2007). Computational studies of Family A and Family B GPCRs. Biochem Soc Trans 35: 749-754.
108. Wittelsberger A, Corich M, Thomas BE, Lee BK, Barazza A, Czodrowski P, et al,. (2006a). The mid-region of parathyroid hormone (1-34) serves as a functional docking domain in receptor activation. Biochemistry 45: 2027-2034.
109. Wittelsberger A, Thomas BE, Mierke DF, Rosenblatt M, (2006b). Methionine acts as a 'magnet' in photoaffinity crosslinking experiments. FEBS Lett 580: 1872-1876.